How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel

American Journal of Medical Genetics, Part A

Volumn 155, Issue 8, 2011, Pages 1877-1883

  Rosenberg, Philip S ^a   Tamary, Hannah ^b   Alter, Blanche P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Epidemiologic methods; Fanconi anemia; Gene frequency; Prevalence

Indexed keywords

ADULT; ARTICLE; BIRTH; CANCER RISK; CONTROLLED STUDY; FANCONI RENOTUBULAR SYNDROME; FEMALE; GENE FREQUENCY; GENETIC SCREENING; HARDY WEINBERG DISTRIBUTION LAW; HETEROZYGOTE; HUMAN; INCIDENCE; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REGISTER; SURVIVAL; UNITED STATES;

ADULT; FANCONI ANEMIA; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENES, RECESSIVE; HETEROZYGOTE; HUMANS; ISRAEL; JEWS; KAPLAN-MEIER ESTIMATE; MALE; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 79960560401     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34087     Document Type: Article

References (46)

1. Altay C, Alikasifoglu M, Kara A, Tuncbilek E, Ozbek N, Schroeder-Kurth TM. 1997. Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience. Clin Genet 51: 296-302.
2. Alter BP. 2003a. Cancer in Fanconi anemia, 1927-2001. Cancer 97: 425-440.
3. Alter BP. 2003b. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, editors. Nathan and Oski's Hematology of Infancy and Childhood, 6th edn. Philadelphia, PA: WB Saunders. pp 280-365.
4. Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr AG, Greene MH, Rosenberg PS. 2010. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure cohort study. Br J Haematol 150: 179-188.
5. Alter BP, Giri N, Savage SA, Rosenberg PS. 2009. Cancer in dyskeratosis congenita. Blood 113: 6549-6557.
6. Auerbach AD. 2009. Fanconi anemia and its diagnosis. Mutat Res 668: 4-10.
7. Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD. 2007. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res 67: 9591-9596.
8. Bouchlaka C, Abdelhak S, Amouri A, Ben A, Hadiji H, Frikha S, Ben M, Othman T, Amri F, Ayadi H, Hachicha M, Rebai A, Saad A, Dellagi K. 2003. Fanconi anemia in Tunisia: High prevalence of group A and identification of new FANCA mutations. J Hum Genet 48: 352-361.
9. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. 1994. Hematologic abnormalities in Fanconi anemia: An international Fanconi anemia registry study. Blood 84: 1650-1655.
10. Callen E, Casado JA, Tischkowitz MD, Bueren JA, Creus A, Marcos R, Dasi A, Estella JM, Munoz A, Ortega JJ, de Winter J, Joenje H, Schindler D, Hanenberg H, Hodgson SV, Mathew CG, Surralles J. 2005. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood 105: 1946-1949.
11. Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellstrom-Lindberg E, Palmblad J, Henter JI, Fadeel B. 2004. Kostmann syndrome: Severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 103: 3355-3361.
12. Cirulli ET, Goldstein DB. 2010. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 11: 415-425.
13. D'Andrea AD. 2010. Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med 362: 1909-1919.
14. de Winter JP, Joenje H. 2009. The genetic and molecular basis of Fanconi anemia. Mutat Res 668: 11-19.
15. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. 2010. Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294.
16. Efron B, Tibshirani R. 1994. In: Cox DR, Hinkley DV, Rubin D, Silverman BW, editors. An introduction to the bootstrap. Boca Raton, Florida: Chapman and Hall.
17. Fares F, Badarneh K, Abosaleh M, Harari-Shaham A, Diukman R, David M. 2008. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: Should the rationale for mutation choice for screening be reevaluated? Prenat Diagn 28: 236-241.
18. Hartl DLC AG. 1997. Principles of population genetics. Sunderland, Massachusetts: Sinauer Associates, Inc.
19. Heim RA, Lench NJ, Swift M. 1992. Heterozygous manifestations in four autosomal recessive human cancer-prone syndromes: Ataxia telangiectasia, xeroderma pigmentosum, Fanconi anemia, and Bloom syndrome. Mutat Res 284: 25-36.
20. Klein JP, Moeschberger ML. 1997. Survival analysis: Techniques for censored and truncated data. New York: Springer-Verlag.
21. Klugman S, Gross SJ. 2010. Ashkenazi Jewish screening in the twenty-first century. Obstet Gynecol Clin North Am 37: 37-46.
22. Korgaonkar S, Ghosh K, Vundinti BR. 2010. Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population. Hematology 15: 58-62.
23. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H, Auerbach AD. 2003. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101: 1249-1256.
24. Macdougall LG, Greeff MC, Rosendorff J, Bernstein R. 1990. Fanconi anemia in black African children. Am J Med Genet 36: 408-413.
25. Macdougall LG, Rosendorff J, Poole JE, Cohn RJ, McElligott SE. 1994. Comparative study of Fanconi anemia in children of different ethnic origin in South Africa. Am J Med Genet 52: 279-284.
26. Magdalena N, Pilonetto DV, Bitencourt MA, Pereira NF, Ribeiro RC, Jeng M, Pasquini R. 2005. Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790 del mutation. Braz J Med Biol Res 38: 669-673.
27. Morgan NV, Essop F, Demuth I, de Ravel T, Jansen S, Tischkowitz M, Lewis CM, Wainwright L, Poole J, Joenje H, Digweed M, Krause A, Mathew CG. 2005. A common Fanconi anemia mutation in black populations of sub-Saharan Africa. Blood 105: 3542-3544.
28. Peleg L, Pesso R, Goldman B, Dotan K, Omer M, Friedman E, Berkenstadt M, Reznik-Wolf H, Barkai G. 2002. Bloom syndrome and Fanconi's anemia: Rate and ethnic origin of mutation carriers in Israel. Isr Med Assoc J 4: 95-97.
29. Potter NU, Sarmousakis C, Li FP. 1983. Cancer in relatives of patients with aplastic anemia. Cancer Genet Cytogenet 9: 61-65.
30. Rosenberg PS. 1995. Hazard function estimation using B-splines. Biometrics 51: 874-887.
31. Rosenberg PS, Greene MH, Alter BP. 2003. Cancer incidence in persons with Fanconi anemia. Blood 101: 822-826.
32. Rosendorff J, Bernstein R, Macdougall L, Jenkins T. 1987. Fanconi anemia: Another disease of unusually high prevalence in the Afrikaans population of South Africa. Am J Med Genet 27: 793-797.
33. Shimamura A, Alter BP. 2010. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 24: 101-122.
34. Strom CM, Crossley B, Redman JB, Quan F, Buller A, McGinniss MJ, Sun W. 2004. Molecular screening for diseases frequent in Ashkenazi Jews: Lessons learned from more than 100, 000 tests performed in a commercial laboratory. Genet Med 6: 145-152.
35. Swift M. 1971. Fanconi's anaemia in the genetics of neoplasia. Nature 230: 370-373.
36. Swift M. 1976. Malignant disease in heterozygous carriers. Birth Defects Orig Artic Ser 12: 133-144.
37. Swift M, Caldwell RJ, Chase C. 1980. Reassessment of cancer predisposition of Fanconi anemia heterozygotes. J Natl Cancer Inst 65: 863-867.
38. Tamary H, Bar-Yam R, Shalmon L, Rachavi G, Krostichevsky M, Elhasid R, Barak Y, Kapelushnik J, Yaniv I, Auerbach AD, Zaizov R. 2000. Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients. Br J Haematol 111: 338-343.
39. Tamary H, Dgany O, Toledano H, Shalev Z, Krasnov T, Shalmon L, Schechter T, Bercovich D, Attias D, Laor R, Koren A, Yaniv I. 2004. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs. Eur J Haematol 72: 330-335.
40. Tamary H, Nishri D, Yacobovich J, Zilber R, Dgany O, Krasnov T, Aviner S, Stepensky P, Ravel-Vilk S, Bitan M, Kaplinsky C, Ben Barak A, Elhasid R, Kapelusnik J, Koren A, Levin C, Attias D, Laor R, Yaniv I, Rosenberg PS, Alter BP. 2010. Frequency and natural history of inherited bone marrow failure syndromes: The Israeli inherited bone marrow failure registry. Haematologica 95: 1300-1307.
41. Tipping AJ, Pearson T, Morgan NV, Gibson RA, Kuyt LP, Havenga C, Gluckman E, Joenje H, de Ravel T, Jansen S, Mathew CG. 2001. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci USA 98: 5734-5739.
42. Tischkowitz M, Easton DF, Ball J, Hodgson SV, Mathew CG. 2008. Cancer incidence in relatives of British Fanconi anaemia patients. BMC Cancer 8: 257.
43. Tootian S, Mahjoubi F, Rahnama M, Hormozian F, Mortezapour F, Razazian F, Manoochehri F, Zamanian M, Nasiri F, Soleymani S, Seyedmortaz L. 2006. Cytogenetic investigation in Iranian patients suspected with Fanconi anemia. J Pediatr Hematol Oncol 28: 834-836.
44. Whitney MA, Jakobs P, Kaback M, Moses RE, Grompe M. 1994. The Ashkenazi Jewish Fanconi anemia mutation: Incidence among patients and carrier frequency in the at-risk population. Hum Mutat 3: 339-341.
45. Xie Y, Hans J, Peng G, Chen Y, Chen L. 2001. Establishment of EBV-immortalized lymphoblast cell lines from three Chinese Fanconi anemia patient and their subtyping. Zhonghua Xue Ye Xue Za Zhi 22: 173-176.
46. Yagasaki H, Oda T, Adachi D, Nakajima T, Nakahata T, Asano S, Yamashita T. 2003. Two common founder mutations of the fanconi anemia group G gene FANCG/XRCC9 in the Japanese population. Hum Mutat 21: 555.